构建和验证一个名录模型,以预测急性二中毒患者的死亡风险
Lu Jiang1,2, Mei Li3, Yinglian Fang4
1Dermatology Department, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University Chengdu 610041, Sichuan, China.
American journal of translational research
|April 14, 2025
概括
这项研究开发了一种名谱,用于预测急性二中毒 (DQ) 患者的死亡率,确定关键风险因素,以便更好地进行临床评估. 该模型在预测患者结果方面表现出高准确度.
科学领域:
- 毒理学 毒理学 毒理学
- 临床医学 临床医学
- 预测建模预测建模
背景情况:
- 急性二中毒 (DQ) 是一个严重的健康问题,死亡率高.
- 有效的风险分层和预测模型对于管理DQ中毒至关重要.
- 目前的临床评估工具在预测DQ中毒患者的死亡率方面可能缺乏准确性.
研究的目的:
- 为了确定与急性二中毒死亡率相关的重大风险因素.
- 开发和验证一个名谱预测模型来评估这些患者的死亡风险.
- 为临床医生提供一种用于预后和资源配置的直观工具.
主要方法:
- 对110名急性DQ中毒患者的回顾性分析.
- 分为培训 (80个案例) 和验证 (30个案例) 集.
- 利用最小绝对收缩和选择运营商 (LASSO) 和多变量后勤回归来确定风险因素.
- 构建并验证了一个名ogram预测模型.
主要成果:
- 选了13个潜在的风险因素,包括DQ剂量,实验室值 (ALT,AST,,肌素,尿素),生理参数 (氧气局部压力) 和严重程度得分 (SIRS,SOFA,APACHE II).
- 开发的诺姆图模型显示出高预测性能,在训练组中,曲线下的面积 (AUC) 为0.961,在验证组中为0.947.
- 校准曲线显示出良好的预测准确度,与理想结果紧密结合.
结论:
- 一个经过验证的诺莫格拉姆模型有效地预测了急性DQ中毒的死亡风险.
- 这种工具为临床医生提供了对患者预后的更清晰理解.
- 该模型可以帮助优化患者治疗策略和医疗资源分配.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
491
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
491
Dosage Regimen Designs: Nomograms and Tabulations
360
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
360
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97


